T1	Protein 27 31	IL-2
T2	Protein 48 51	CD4
T3	Protein 220 223	CD4
T4	Protein 308 312	IL-2
T5	Protein 555 561	p59fyn
T6	Protein 566 574	CD3 zeta
T7	Protein 737 741	IL-2
T8	Protein 800 804	IL-2
T9	Protein 950 953	p50
T10	Protein 954 957	p65
T11	Protein 1904 1908	IL-2
T36	Exp 666 686	downstream signaling
R4	Coref Anaphora:T16 Antecedent:T15
R5	Coref Anaphora:T17 Antecedent:T36
R6	Coref Anaphora:T29 Antecedent:T30
T13	Exp 23 40	the IL-2 promoter
T14	Exp 170 239	The inert quality of MRL-Ipr/Ipr (Ipr) peripheral CD4-CD8- (CD4-8-) T
T15	Exp 362 378	these same cells
T16	Exp 507 511	They
T17	Exp 687 691	that
T18	Exp 601 615	The generation
T19	Exp 733 746	the IL-2 gene
T20	Exp 748 750	We
T21	Exp 772 792	the activation state
T22	Exp 796 825	the IL-2 gene promoter region
T23	Exp 925 936	the octamer
T24	Exp 1089 1112	the activated phenotype
T25	Exp 1116 1127	these cells
T26	Exp 1174 1201	the transactivating complex
T27	Exp 1304 1314	the levels
T28	Exp 1318 1346	the activating NF-AT complex
T29	Exp 1544 1549	which
T30	Exp 1528 1542	the NF-AT site
T31	Exp 1652 1672	the binding activity
T32	Exp 1676 1706	the novel NF-AT-binding factor
T33	Exp 1830 1844	the NF-AT site
T34	Exp 1890 1900	the defect
T35	Exp 1803 1826	These two abnormalities
